Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Alentis Clinical Trial Contact
CONTACT
Lead
Alentis Therapeutics AG
This Study has a Phase I ALE.P02 monotherapy dose escalation and recommended dose for expansion (RDE) study of ALE.P02 as a monotherapy and combination therapy with pembrolizumab, and a Phase II study of ALE.P02 as a monotherapy at RP2D in adult patients with selected advanced or metastatic Claudin-1 positive (CLDN1+) cancers.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted